Wolf JL - Search Results

1

Mucinous adenocarcinoma arising in congenital pulmonary airway malformation: clinicopathological analysis of 37 cases.

Chang WC, Zhang YZ, Wolf JL, Hermelijn SM, Schnater JM, von der Thüsen JH, Rice A, Lantuejoul S, Mastroianni B, Farver C, Black F, Popat S, Nicholson AG. Chang WC, et al. Among authors: wolf jl. Histopathology. 2021 Feb;78(3):434-444. doi: 10.1111/his.14239. Epub 2020 Oct 23. Histopathology. 2021. PMID: 32810914 Free article.

2

Interobserver variation in the classification of thymic lesions including biopsies and resection specimens in an international digital microscopy panel.

Wolf JL, van Nederveen F, Blaauwgeers H, Marx A, Nicholson AG, Roden AC, Ströbel P, Timens W, Weissferdt A, von der Thüsen J, den Bakker MA. Wolf JL, et al. Histopathology. 2020 Nov;77(5):734-741. doi: 10.1111/his.14167. Epub 2020 Sep 24. Histopathology. 2020. PMID: 32506527 Free PMC article.

3

Early KRAS oncogenic driver mutations in nonmucinous tissue of congenital pulmonary airway malformations as an indicator of potential malignant behavior.

Hermelijn SM, Wolf JL, Dorine den Toom T, Wijnen RMH, Rottier RJ, Schnater JM, von der Thüsen JH. Hermelijn SM, et al. Among authors: wolf jl. Hum Pathol. 2020 Sep;103:95-106. doi: 10.1016/j.humpath.2020.07.015. Epub 2020 Jul 16. Hum Pathol. 2020. PMID: 32681943 Free article.

4

ETV6-NTRK3 translocation-associated low-grade mucinous bronchial adenocarcinoma: A novel bronchial salivary gland-type non-small cell lung cancer subtype.

von der Thüsen JH, Dumoulin DW, Maat APWM, Wolf J, Sadeghi AH, Aerts JGJV, Cornelissen R. von der Thüsen JH, et al. Lung Cancer. 2021 Jun;156:72-75. doi: 10.1016/j.lungcan.2021.04.015. Epub 2021 Apr 16. Lung Cancer. 2021. PMID: 33895680 Free article.

5

Quantitative CT imaging analysis to predict pathology features in patients with a congenital pulmonary airway malformation.

Hermelijn SM, Mackenbach MJ, van Horik C, Ciet P, Wolf JL, von der Thüsen JH, Wijnen RMH, Tiddens HAWM, Schnater JM. Hermelijn SM, et al. Among authors: wolf jl. J Pediatr Surg. 2022 Aug;57(8):1567-1572. doi: 10.1016/j.jpedsurg.2021.10.008. Epub 2021 Oct 14. J Pediatr Surg. 2022. PMID: 34809963

6

Prevalence, clinical and molecular characteristics of early stage EGFR-mutated lung cancer in a real-life West-European cohort: Implications for adjuvant therapy.

Hondelink LM, Ernst SM, Atmodimedjo P, Cohen D, Wolf JL, Dingemans AC, Dubbink HJ, von der Thüsen JH. Hondelink LM, et al. Among authors: wolf jl. Eur J Cancer. 2023 Mar;181:53-61. doi: 10.1016/j.ejca.2022.12.010. Epub 2022 Dec 19. Eur J Cancer. 2023. PMID: 36638752 Free article.

7

Artificial intelligence-based recurrence prediction outperforms classical histopathological methods in pulmonary adenocarcinoma biopsies.

Akram F, Wolf JL, Trandafir TE, Dingemans AC, Stubbs AP, von der Thüsen JH. Akram F, et al. Among authors: wolf jl. Lung Cancer. 2023 Dec;186:107413. doi: 10.1016/j.lungcan.2023.107413. Epub 2023 Nov 4. Lung Cancer. 2023. PMID: 37939498 Free article.

8

Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?

Najjary S, Kros JM, de Koning W, Vadgama D, Lila K, Wolf J, Mustafa DAM. Najjary S, et al. Acta Neuropathol Commun. 2023 Apr 15;11(1):64. doi: 10.1186/s40478-023-01542-9. Acta Neuropathol Commun. 2023. PMID: 37061716 Free PMC article.

9

Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma.

Fortuna GG, Banerjee R, Savid-Frontera C, Song J, Morán-Segura CM, Nguyen JV, Lekakis L, Fernandez-Pol S, Samraj AN, Naresh KN, Vazquez-Martinez M, Baz RC, Spiegel JY, Mikkilineni L, Gubatan JM, Sidana S, de Menezes Silva Corraes A, Kalariya NM, Patel KK, Shim KG, Fonseca R, Ferreri C, Voorhees PM, Richard S, Valdes CR, Sireesha Asoori, Wolf JL, Cowan AJ, Sborov DW, Locke FL, Lin Y, Wang Y, Hansen DK. Fortuna GG, et al. Among authors: wolf jl. Blood Cancer J. 2024 Oct 16;14(1):180. doi: 10.1038/s41408-024-01167-8. Blood Cancer J. 2024. PMID: 39414769 Free PMC article.

10

Improved ex vivo fluorescence imaging of human head and neck cancer using the peptide tracer TPP-IRDye800 targeting membrane-bound Hsp70 on tumor cells.

Holzmann KLK, Wolf JL, Stangl S, Lennartz P, Kasajima A, Mogler C, Haller B, Ebert EV, Jira D, Lauterbach MLA, von Meyer F, Stark L, Mauch L, Schmidl B, Wollenberg B, Multhoff G, Wirth M. Holzmann KLK, et al. Among authors: wolf jl. Br J Cancer. 2024 Oct 15. doi: 10.1038/s41416-024-02872-8. Online ahead of print. Br J Cancer. 2024. PMID: 39406917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters